238 related articles for article (PubMed ID: 16249257)
1. Dual mechanism of the potentiation by glucose of insulin secretion induced by arginine and tolbutamide in mouse islets.
Ishiyama N; Ravier MA; Henquin JC
Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E540-9. PubMed ID: 16249257
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological approach to understanding the control of insulin secretion in human islets.
Henquin JC; Dufrane D; Gmyr V; Kerr-Conte J; Nenquin M
Diabetes Obes Metab; 2017 Aug; 19(8):1061-1070. PubMed ID: 28116849
[TBL] [Abstract][Full Text] [Related]
3. Tolbutamide and diazoxide influence insulin secretion by changing the concentration but not the action of cytoplasmic Ca2+ in beta-cells.
Mariot P; Gilon P; Nenquin M; Henquin JC
Diabetes; 1998 Mar; 47(3):365-73. PubMed ID: 9519741
[TBL] [Abstract][Full Text] [Related]
4. Activators of PKA and Epac distinctly influence insulin secretion and cytosolic Ca2+ in female mouse islets stimulated by glucose and tolbutamide.
Henquin JC; Nenquin M
Endocrinology; 2014 Sep; 155(9):3274-87. PubMed ID: 24977470
[TBL] [Abstract][Full Text] [Related]
5. Effect of 17beta-estradiol on insulin secretion and cytosolic calcium in Min6 mouse insulinoma cells and human islets of Langerhans.
Al-Majed HT; Squires PE; Persaud SJ; Huang GC; Amiel S; Whitehouse BJ; Jones PM
Pancreas; 2005 May; 30(4):307-13. PubMed ID: 15841038
[TBL] [Abstract][Full Text] [Related]
6. Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells.
Schöfl C; Börger J; Mader T; Waring M; von zur Mühlen A; Brabant G
Am J Physiol Endocrinol Metab; 2000 Apr; 278(4):E639-47. PubMed ID: 10751197
[TBL] [Abstract][Full Text] [Related]
7. Human islets chronically exposed in vitro to different stimuli become unresponsive to the same stimuli given acutely: evidence supporting specific desensitization rather than beta-cell exhaustion.
Davalli AM; Pontiroli AE; Socci C; Bertuzzi F; Fattor B; Braghi S; Di Carlo V; Pozza G
J Clin Endocrinol Metab; 1992 Apr; 74(4):790-4. PubMed ID: 1548342
[TBL] [Abstract][Full Text] [Related]
8. The permissive effect of glucose, tolbutamide and high K+ on arginine stimulation of insulin release in isolated mouse islets.
Hermans MP; Schmeer W; Henquin JC
Diabetologia; 1987 Aug; 30(8):659-65. PubMed ID: 3308605
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of insulin secretion to nonglucose stimuli in normal man by tolbutamide.
Pfeifer MA; Halter JB; Graf R; Porte D
Diabetes; 1980 May; 29(5):335-40. PubMed ID: 6991327
[TBL] [Abstract][Full Text] [Related]
10. Effects of glucose, forskolin and tolbutamide on membrane potential and insulin secretion in the insulin-secreting cell line INS-1.
Ullrich S; Abel KB; Lehr S; Greger R
Pflugers Arch; 1996 Aug; 432(4):630-6. PubMed ID: 8764963
[TBL] [Abstract][Full Text] [Related]
11. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator.
Johnson D; Shepherd RM; Gill D; Gorman T; Smith DM; Dunne MJ
Diabetes; 2007 Jun; 56(6):1694-702. PubMed ID: 17360975
[TBL] [Abstract][Full Text] [Related]
12. Alterations of insulin response to different beta cell secretagogues and pancreatic vascular resistance induced by N omega-nitro-L-arginine methyl ester.
Gross R; Roye M; Manteghetti M; Hillaire-Buys D; Ribes G
Br J Pharmacol; 1995 Oct; 116(3):1965-72. PubMed ID: 8640333
[TBL] [Abstract][Full Text] [Related]
13. Insulin secretion to glucose as well as nonglucose stimuli is impaired in spontaneously diabetic Nagoya-Shibata-Yasuda mice.
Hamada Y; Ikegami H; Ueda H; Kawaguchi Y; Yamato E; Nojima K; Yamada K; Babaya N; Shibata M; Ogihara T
Metabolism; 2001 Nov; 50(11):1282-5. PubMed ID: 11699045
[TBL] [Abstract][Full Text] [Related]
14. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
Rustenbeck I; Dickel C; Grimmsmanns T
Biochem Pharmacol; 2001 Dec; 62(12):1695-703. PubMed ID: 11755123
[TBL] [Abstract][Full Text] [Related]
15. Tolbutamide stimulation of pancreatic beta-cells involves both cell recruitment and increase in the individual Ca(2+) response.
Jonkers FC; Guiot Y; Rahier J; Henquin JC
Br J Pharmacol; 2001 Jun; 133(4):575-85. PubMed ID: 11399675
[TBL] [Abstract][Full Text] [Related]
16. Beta-cell memory to insulin secretagogues: characterization of the time-dependent inhibitory control system in the isolated rat pancreas.
Nesher R; Eylon L; Segal N; Cerasi E
Endocrinology; 1989 Jan; 124(1):142-8. PubMed ID: 2462485
[TBL] [Abstract][Full Text] [Related]
17. Alterations of insulin secretion from mouse islets treated with sulphonylureas: perturbations of Ca2+ regulation prevail over changes in insulin content.
Anello M; Gilon P; Henquin JC
Br J Pharmacol; 1999 Aug; 127(8):1883-91. PubMed ID: 10482920
[TBL] [Abstract][Full Text] [Related]
18. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
Sato Y; Anello M; Henquin JC
Endocrinology; 1999 May; 140(5):2252-7. PubMed ID: 10218978
[TBL] [Abstract][Full Text] [Related]
19. L-arginine stimulation of glucose-induced insulin secretion through membrane depolarization and independent of nitric oxide.
Thams P; Capito K
Eur J Endocrinol; 1999 Jan; 140(1):87-93. PubMed ID: 10037257
[TBL] [Abstract][Full Text] [Related]
20. Cyclic nucleotides in pancreatic islets. Tolbutamide- and arginine-induced insulin release.
Charles MA; Lawecki J; Steiner AL; Grodsky GM
Diabetes; 1976 Apr; 25(4):256-9. PubMed ID: 178555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
